KMID : 0881720210360050363
|
|
Journal of Food Hygiene and Safety 2021 Volume.36 No. 5 p.363 ~ p.375
|
|
Role of Peptides in Antiviral (COVID-19) Therapy
|
|
Chelliah Ramachandran
Daliri Eric Banan-Mwine Elahi Fazle Yeon Su-Jung Tyagi Akanksha Park Chae-Rin Kim Eun-Ji Hee Jo-Kyoung Oh Deog-Hwan
|
|
Abstract
|
|
|
Trends in the developing era to discover and design peptide-based treatments throughout an epidemic infection scenario such as COVID-19 could progress into a more efficient and low-cost therapeutic environment. However, the weakening of proteolysis is one downside of natural peptide drugs. But, peptidomimetics may help resolve this issue. In this review, peptide and peptide-based drug discovery were summarized to target one key entry mechanism of severe coronavirus pulmonary emboli syndrome (SARS-CoV-2), which encompasses the association of the host angiotensin-converting enzyme-2 (ACE2) receptor and viral spike (S) protein. Furthermore, the benefits of proteins, peptides and other possible actions that have been studied for COVID-19 through new peptide-based treatments are discussed in the review. Lastly, an overview of the peptide-based drug therapy environment is comprised of an evolutionary viewpoint, structural properties, operational thresholds, and an explanation of the therapeutic area.
|
|
KEYWORD
|
|
Peptides, COVID-19, Angiotensin-converting enzyme-2 (ACE2) receptor, Drug therapy
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|